These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 12154098)
21. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice. Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462 [TBL] [Abstract][Full Text] [Related]
22. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells. Clarke CJ; Cloessner EA; Roddy PL; Hannun YA Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347 [TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. Yang Z; Costanzo M; Golde DW; Kolesnick RN J Biol Chem; 1993 Sep; 268(27):20520-3. PubMed ID: 8376408 [TBL] [Abstract][Full Text] [Related]
24. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells. Sawada M; Nakashima S; Kiyono T; Yamada J; Hara S; Nakagawa M; Shinoda J; Sakai N Exp Cell Res; 2002 Feb; 273(2):157-68. PubMed ID: 11822871 [TBL] [Abstract][Full Text] [Related]
25. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Wiegmann K; Schütze S; Machleidt T; Witte D; Krönke M Cell; 1994 Sep; 78(6):1005-15. PubMed ID: 7923351 [TBL] [Abstract][Full Text] [Related]
26. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. Schwandner R; Wiegmann K; Bernardo K; Kreder D; Kronke M J Biol Chem; 1998 Mar; 273(10):5916-22. PubMed ID: 9488730 [TBL] [Abstract][Full Text] [Related]
27. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. Wiegmann K; Schwandner R; Krut O; Yeh WC; Mak TW; Krönke M J Biol Chem; 1999 Feb; 274(9):5267-70. PubMed ID: 10026132 [TBL] [Abstract][Full Text] [Related]
28. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. Adam D; Wiegmann K; Adam-Klages S; Ruff A; Krönke M J Biol Chem; 1996 Jun; 271(24):14617-22. PubMed ID: 8663014 [TBL] [Abstract][Full Text] [Related]
30. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. Liu B; Hannun YA J Biol Chem; 1997 Jun; 272(26):16281-7. PubMed ID: 9195931 [TBL] [Abstract][Full Text] [Related]
32. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries. Moral-Sanz J; Gonzalez T; Menendez C; David M; Moreno L; Macias A; Cortijo J; Valenzuela C; Perez-Vizcaino F; Cogolludo A Am J Physiol Cell Physiol; 2011 Jul; 301(1):C186-94. PubMed ID: 21490312 [TBL] [Abstract][Full Text] [Related]
33. Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation. Supinski GS; Alimov AP; Wang L; Song XH; Callahan LA Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L614-24. PubMed ID: 26138644 [TBL] [Abstract][Full Text] [Related]
34. Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase. Angulo S; Morales A; Danese S; Llacuna L; Masamunt MC; Pultz N; Cifone MG; De Simone C; Delgado S; Vila J; Panés J; Donskey C; Fernández-Checa JC; Fiocchi C; Sans M PLoS One; 2011 Mar; 6(3):e16953. PubMed ID: 21408067 [TBL] [Abstract][Full Text] [Related]
35. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. Testai FD; Landek MA; Dawson G J Neurosci Res; 2004 Jan; 75(1):66-74. PubMed ID: 14689449 [TBL] [Abstract][Full Text] [Related]
36. Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease. Jana A; Pahan K J Neurosci; 2010 Sep; 30(38):12676-89. PubMed ID: 20861373 [TBL] [Abstract][Full Text] [Related]
37. Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction. Coblentz PD; Ahn B; Hayward LF; Yoo JK; Christou DD; Ferreira LF Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L679-L690. PubMed ID: 30702345 [TBL] [Abstract][Full Text] [Related]
38. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. Kanety H; Hemi R; Papa MZ; Karasik A J Biol Chem; 1996 Apr; 271(17):9895-7. PubMed ID: 8626623 [TBL] [Abstract][Full Text] [Related]
39. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats. Babenko NA; Kharchenko VS Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045 [TBL] [Abstract][Full Text] [Related]
40. Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. Takeda Y; Tashima M; Takahashi A; Uchiyama T; Okazaki T J Biol Chem; 1999 Apr; 274(15):10654-60. PubMed ID: 10187863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]